TET2 and acute myeloid leukemia: For example, TET2 mutations are found recurrently in AML, MDS, MPN and chronic myelomonocytic leukaemia (CMML), as well as occurring in lymphoid tumours (Delhommeau et al., 2009; Quivoron et al., 2011).